FDA approves ‘female Viagra’ with strong warning

Handout photo shows the drug, flibanserin, under the trade name Addyi, nicknamed "female Viagra"By Toni Clarke WASHINGTON (Reuters) – A controversial drug to treat low sexual desire in women won approval from U.S. health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting when taken with alcohol. The FDA has twice rejected the drug, flibanserin, made by privately held Sprout Pharmaceuticals. Its latest decision comes after an advisory panel concluded in June it should be approved with strict measures in place to ensure patients are fully aware of the risks.



Medications/Drugs News Headlines – Yahoo! News

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us